Market revenue in 2023 | USD 68.7 million |
Market revenue in 2030 | USD 114.2 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Jet |
Fastest growing segment | Mesh |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Jet, Mesh, Ultrasonic |
Key market players worldwide | OMRON Corp, GE HealthCare Technologies Inc Common Stock, Koninklijke Philips NV, Allied Healthcare Products Inc, DeVilbiss Healthcare, Briggs Healthcare Corp., Beurer, PARI Group, Philip Morris International Inc, Aerogen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nebulizer market will help companies and investors design strategic landscapes.
Jet was the largest segment with a revenue share of 65.5% in 2023. Horizon Databook has segmented the Japan nebulizer market based on jet, mesh, ultrasonic covering the revenue growth of each sub-segment from 2018 to 2030.
The nebulizers market in Japan is expected to witness a lucrative growth over the forecast period owing to the availability of abundant skilled labor in the healthcare sector, rise in geriatric population, and presence of supportive government policies.
Premiums and outof-pocket payments are as per the amount fixed by the government (30% of service cost to be paid up to the age of 70 years, 10%–20% from 70 to 74 years of age, and only 10% from 74 years and beyond). Geriatric population is susceptible to pulmonary disorders; owing to which, a significant number of surgical interventions would to be required.
According to a study conducted by the Japanese government, the annual exacerbation rates in Japan are about 0.1–2.1 and 0.33 to 1.79, respectively. Moreover, as per health data of Japan, COPD and other respiratory diseases were responsible for 25.2% and 30.0% of the total number of deaths, respectively, in Japan in 2017.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan nebulizer market , including forecasts for subscribers. This country databook contains high-level insights into Japan nebulizer market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account